(VIANEWS) – Shares of Canopy Growth (NASDAQ: CGC) slid by a staggering 24.79% in 10 sessions from $1.17 at 2023-05-22, to $0.88 at 23:15 EST on Monday, after five consecutive sessions in a row of losses. NASDAQ is rising 2.19% to $12,975.69, after two consecutive sessions in a row of gains.
Canopy Growth’s last close was $0.88, 87.16% below its 52-week high of $6.83.
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
Earnings Per Share
As for profitability, Canopy Growth has a trailing twelve months EPS of $-4.36.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -112%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 28.2%, now sitting on 440.96M for the twelve trailing months.
Sales Growth
Canopy Growth’s sales growth is negative 11.9% for the present quarter and negative 6.7% for the next.
Yearly Top and Bottom Value
Canopy Growth’s stock is valued at $0.88 at 23:15 EST, way under its 52-week low of $1.43.
More news about Canopy Growth (CGC).
